According to Chemed's latest financial reports the company's current EPS (TTM) is $15.15. In 2022 the company made an earnings per share (EPS) of $16.72 a decrease over its 2021 EPS that were of $17.16.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $15.15 | -9.39% |
2022 | $16.72 | -2.56% |
2021 | $17.16 | -14.33% |
2020 | $20.03 | 45.57% |
2019 | $13.76 | 7.5% |
2018 | $12.80 | 109.49% |
2017 | $6.11 | -8.12% |
2016 | $6.65 | 1.68% |
2015 | $6.54 | 12.95% |
2014 | $5.79 | 35.92% |
2013 | $4.26 | -10.13% |
2012 | $4.74 | 13.13% |
2011 | $4.19 | 15.75% |
2010 | $3.62 | 10.03% |
2009 | $3.29 | 14.24% |
2008 | $2.88 | 10.34% |
2007 | $2.61 | 34.54% |
2006 | $1.94 | 38.57% |
2005 | $1.40 | 29.03% |
2004 | $1.08 | -571.74% |
2003 | -$0.23 | 15% |
2002 | -$0.20 | -68.25% |
2001 | -$0.63 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() LHC Group LHCG | $2.06 | -86.40% | ๐บ๐ธ USA |
![]() Amedisys AMED | $0.09000 | -99.41% | ๐บ๐ธ USA |
![]() Balchem BCPC | $3.09 | -79.57% | ๐บ๐ธ USA |
![]() Sensient Technologies
SXT | $3.17 | -79.08% | ๐บ๐ธ USA |